A Comparative Study of Ampicillin/Sulbactam Versus Moxifloxacin in the Treatment of Complicated Intra-abdominal Infections
Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
On the basis of monotherapy for intra-abdominal infection, the investigators are conducting
this study to identify the difference of drug efficacy between ampicillin/sulbactam and
moxifloxacin.
Phase:
Phase 4
Details
Lead Sponsor:
Kaohsiung Medical University Chung-Ho Memorial Hospital
Treatments:
Ampicillin Fluoroquinolones Moxifloxacin Norgestimate, ethinyl estradiol drug combination Sulbactam Sultamicillin